Searched for
PFIZER FINANCIAL FORECASTING
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
Why US stock market Dow Jones, S&P 500 and Nasdaq are surging big today: Dow jumps 350 points, Nasdaq jumps 250 points as Intel hits all-time high driving the rallyUS stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...
Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera: ReportPfizer is close to acquiring Metsera, an anti-obesity drug developer. The deal could be worth $7.3 billion. Pfizer will pay $47.50 per shar...
Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
Vaccine maker Moderna forecasts lower sales next year, shares tumble 17% to near four-year lowModerna has delayed its break-even goal by two years, pushing it to 2028, due to slower regulatory processes for key products like flu and ...
Life after Covid turns rocky for reshaped health-care businesses like Pfizer to ModernaThe waning of the COVID-19 pandemic is reshaping the healthcare industry once again. Vaccine makers and pharmacy chains are seeing a declin...
Pfizer Q2 Results: Profit tumbles 77% to $2.3 billion; co trims 2023 revenue outlookThese include US approval for a drug combination for prostate cancer and a needed recommendation on the Abrysvo vaccine from the US Centers...
AstraZeneca jab uncertainty will hit Oxford BioMedica’s revenueIn a recent report, Oxford Biomedica warned that uncertainty surrounding AstraZeneca’s Covid-19 contract will bring reduction in earnings t...
Unilever will not raise rejected 50 bn pound bid for GSK consumer armGSK has rejected three bids from Unilever for its consumer arm, which is home to brands such as Sensodyne toothpaste, Emergen-C vitamin sup...
Wall Street extends record rally on strong jobs reportTen of the 11 major S&P sectors advanced in early trading, with economy-sensitive energy, financials and industrials gaining more than 1 pe...
With more Covid jabs around, will the rally in cyclicals come roaring back?The breathtaking rally seen in the cyclical stocks since earlier this year halted in the past few sessions, as investors shifted money to d...
Dubai economy to grow 4% in 2021, rebounding from this year's contractionDubai Statistic Centre said the economy declined by 10.8% in the first six months of 2020, which the centre's executive director, Arif Al M...
WHO vaccine scheme risks failure, leaving poor countries no COVID shots until 2024The World Health Organization's COVAX programme is the main global scheme to vaccinate people in poor and middle income countries around th...
American CEOs most bearish on earnings since 2008 crisisAnalysts now expect per-share earnings from S&P 500 companies to decline 2.1% in the first quarter and fall 1.1% over the following period.
- Pfizer 4Q profit beats views as revenue up 6 pc
Pfizer Inc.'s new CEO on Tuesday outlined plans to reduce the company's spending and work force and focus more sharply on promising drugs a...
- Pfizer 3Q profit down 70 pc due to charges
Pfizer Inc said on Tuesday that revenue in the third quarter jumped 39 per cent, but hefty charges related to that $68 billion purchase dra...
- Pfizer profit dips 2 percent, sales fall much more
Pfizer Inc posted a 2 percent drop in first-quarter profit Tuesday, as cost-cutting by the world's largest drugmaker couldn't offset big dr...
- Bristol-Myers to shut half of its plants in 3 years
Apart from plant shutdowns, the company plans to lay off about 4,300 employees in a broad restructuring aimed at cost savings of $1.5 b by ...
- J&J profits rise 9 per cent
Health care products maker Johnson & Johnson on Tuesday posted a 9 percent increase in its second-quarter profit
- Earnings of consumer cos may be critical for US stocks
Consumer-oriented companies are early leaders among US stocks this year. Earnings reports that start pouring in from Wednesday are likely t...